Tzu-Tshin Wong

This inventor holds 13 USPTO granted patents, plus 3 CIPO patents and 4 EPO patents. Top assignees: Millennium Pharmaceuticals Limited, Cornell University, Tri-Institutional Therapeutics Discovery Institute. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tzu-Tshin Wong. Retrieved from https://idiyas.com/inventor/tzu-tshin-wong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 13.2

ph-index = 3

Forward Citations = 23(Granted Patents)

Location History:

Belmont, MA (US) (2016 - 2019)
Acton, MA (US) (2017 - 2023)

Company Filing History:

7 out of 855

Millennium Pharmaceuticals Limited

Tri-Institutional Therapeutics Discovery Institute

patents

4. 2 out of 1,228

Takeda Pharmaceutical Company Limited

patents

5. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473331 - Macrocyclic compounds as proteasome inhibitors (2025-11-18),

2. 11834515 - Macrocyclic compounds as proteasome inhibitors (2023-12-05),

3. 11732005 - Peptidomimetic proteasome inhibitors (2023-08-22),

4. 11203613 - Peptidomimetic proteasome inhibitors (2021-12-21),

5. 10538533 - Heteroaryls and uses thereof (2020-01-21),

6. 10519110 - Heterocyclic compound (2019-12-31),

7. 10202389 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme (2019-02-12),

8. 10189785 - Heterocyclic compound (2019-01-29),

9. 9802960 - Heteroaryls and uses thereof (2017-10-31),

10. 9796725 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme (2017-10-24),

11. 9751854 - Heteroaryls and uses thereof (2017-09-05),

12. 9663525 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme (2017-05-30),

13. 9290500 - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme (2016-03-22),

Title: The Innovations of Tzu-Tshin Wong

Introduction

Tzu-Tshin Wong is a notable inventor based in Acton, MA, with a remarkable portfolio of 12 patents. His work primarily focuses on the development of innovative compounds that have significant implications in the medical field.

Latest Patents

Wong's latest patents include "Macrocyclic compounds as proteasome inhibitors." These compounds are designed to treat various conditions, including bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases, inflammatory disorders, and muscular dystrophy. They also provide immunosuppression for transplanted organs or tissues. Another significant patent is "Peptidomimetic proteasome inhibitors," which shares similar applications in treating a wide range of diseases and disorders.

Career Highlights

Throughout his career, Tzu-Tshin Wong has worked with prominent organizations such as Millennium Pharmaceuticals Limited and Cornell University. His contributions to these institutions have been instrumental in advancing research and development in the pharmaceutical field.

Collaborations

Wong has collaborated with notable colleagues, including Indu T Bharathan and Jeffrey P Ciavarri, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Tzu-Tshin Wong's innovative work in developing proteasome inhibitors showcases his commitment to addressing critical health challenges. His contributions continue to influence the medical field significantly.

Profile summary based on public USPTO records.